As of Jun 30
| +0.44 / +0.57%|
The 18 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 80.00, with a high estimate of 89.00 and a low estimate of 60.00. The median estimate represents a +2.56% increase from the last price of 78.00.
The current consensus among 25 polled investment analysts is to Hold stock in St. Jude Medical. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.